Tibolone 2.5 mg
Consumer Medicine Information
This leaflet answers some common questions about Livial. It does not contain all the available information.
It does not take the place of talking to your doctor or pharmacist.
All medicines have risks and benefits. Your doctor has weighed the risks of you taking Livial against the benefits they expect it will have for you.
If you have any concerns about taking this medicine, ask your doctor or pharmacist.
Keep this information with the pack. You may wish to read it again.
Livial tablets contain the active ingredient tibolone, which is a synthetic steroid medicine used for hormone replacement therapy (HRT). It mimics the activity of the female sex hormones in the body.
Livial contains tibolone, a substance that has favourable effects on different tissues in the body, such as brain, vagina and bone. Livial is used in postmenopausal women at least 12 months since their last natural period.
Livial is used for:
Relief of symptoms occurring after menopause
During the menopause, the amount of oestrogen produced by a woman's body drops. This can cause symptoms such as hot face, neck and chest ("hot flushes"). Livial alleviates these symptoms after menopause. You will only be prescribed Livial if your symptoms seriously hinder your daily life.
Prevention of osteoporosis
After the menopause some women may develop fragile bones (osteoporosis). You should discuss all available options with your doctor.
If you are at an increased risk of fractures due to osteoporosis and other medicines are not suitable for you, you can take Livial to prevent osteoporosis after menopause.
Livial is not a contraceptive.
Livial has no effect on alertness and concentration as far as is known.
A doctor's prescription is required to obtain this medicine.
Do not take Livial if:
Some of the symptoms of an allergic reaction may include:
If any of the above conditions appear for the first time while taking Livial, stop taking it at once and consult your doctor immediately.
As well as benefits, HRT or Livial has some risks which need to be considered when deciding whether to starting taking it, or whether to carry on taking it.
The experience in treating women with a premature menopause (due to ovarian failure or surgery) is limited. If you have a premature menopause the risks of using HRT or Livial may be different. Please talk to your doctor.
Before you start (or restart) HRT or Livial, your doctor will ask you about your own and your family's medical history. Your doctor may decide to perform a physical examination. This may include an examination of your breasts and/or an internal examination, if necessary.
Once you have started on Livial, you should see your doctor for regular check-ups (at least once a year). At these check-ups, discuss with your doctor the benefits and risks of continuing with Livial.
Go for regular breast screening, as recommended by your doctor.
Tell your doctor if you have ever had any of the following conditions before you start the treatment, as these may return or become worse during treatment with Livial. If so, you should see your doctor more often for check-ups:
Tell your doctor if you notice any change in your condition whilst using Livial.
Stop taking Livial and see a doctor immediately if you notice any of the following when taking HRT or Livial:
Excessive thickening of the lining of the womb (endometrial hyperplasia) and cancer of the lining of the womb (endometrial cancer)
There have been reports and studies of an increased cell growth or cancer of the lining of the womb in women using Livial. The risk of cancer of the lining of the womb increases with the duration of use.
You may have irregular bleeding or drops of blood (spotting) during the first 3-6 months of taking Livial.
However, if the irregular bleeding:
See your doctor as soon as possible.
Taking oestrogen, oestrogen-progesterone combined HRT or Livial for several years slightly increases the risk of breast cancer. The risk increases with the duration of HRT use and returns to normal within about 5 years after stopping HRT.
Women taking Livial have a lower risk than women using combined HRT and a comparable risk with oestrogen-only HRT.
Regularly check your breasts. See your doctor if you notice any changes such as:
Ovarian cancer (cancer of the ovaries) is very rare, but it is serious. It can be difficult to diagnose, because there are no obvious signs of the disease.
Heart disease (heart attack)
Livial is not recommended for women who have heart disease, or have had heart disease recently. If you have ever had heart disease, talk to your doctor to see if you should be taking Livial.
Studies with one type of HRT (containing conjugated oestrogen plus the progestogen medroxyprogesterone acetate) have shown that women may be slightly more likely to get heart disease during the first year of taking medication. For other types of HRT including Livial; the risk may be similar, although this is not yet certain.
See a doctor as soon as possible and do not take any more Livial if you get a pain in your chest that spreads to your arm or neck.
This pain could be a sign of heart disease.
Recent research suggests that HRT and Livial increases the risk of having a stroke. This increased risk has mainly been observed in elderly postmenopausal women above 60 years of age.
If you are worried about any of these things, or if you have had a stroke in the past, talk to your doctor to see if you should take Livial.
See a doctor as soon as possible and do not take any more Livial until your doctor says you can if you get any unexplained migraine-type headaches with or without disturbed vision.
These headaches may be an early warning sign of a stroke.
Blood clots in a vein (Thrombosis)
Oestrogen and oestrogen-progestogen combined HRT may increase the risk of blood clots in the veins (also called deep vein thrombosis, or DVT), especially during the 1st year of taking it. It is unknown if Livial increases the risk in the same way.
Blood clots can be serious, and if one travels to the lungs, it can cause chest pain, breathlessness, fainting or even death. You are more likely to get a blood clot in your veins as you get older and if any of the following applies to you.
Inform your doctor if any of these situations apply to you:
If any of these apply to you, talk to your doctor about whether you should use Livial.
For signs of a blood clot, see "Stop taking Livial and see a doctor immediately".
HRT will not prevent memory loss. There is some evidence of a higher risk of memory loss in women who start using HRT after the age of 65. Speak to your doctor for advice.
Tell your doctor if you become pregnant or are breast-feeding. Livial is for use in postmenopausal women only. If you are pregnant or breast-feeding or think you may be pregnant, do not take Livial.
Tell your doctor if you react badly to lactose or milk before you start taking Livial. Livial tablets contain lactose.
Tell your doctor or pharmacist if you are taking any other medicines, including medicines that you get without a prescription, herbal medicines or other natural products from your pharmacy, supermarket or health food shop.
Some medicines may interfere with the effect of Livial.
This applies to the following medicines:
Your doctor may need to adjust the dose of these medicines.
Ask your doctor or pharmacist for advice before taking any medicine.
Livial should not be taken until 12 months after your last natural menstrual bleed. If Livial is taken sooner than this, the chance of irregular vaginal bleeding may be increased.
Women who have undergone premature menopause (surgical removal of ovaries) can start taking Livial immediately.
If you are already using a different type of HRT, your doctor will advise you when to switch to Livial.
Take Livial as directed by your doctor. You should also read the instructions given in this leaflet for your medicine. If you are not sure how to take Livial ask your doctor or pharmacist.
Take one tablet daily, at about the same time each day. Swallow the tablet with some water or other non-alcoholic drink.
The Livial pack contains 28 white tablets. The strips with Livial are marked with the days of the week. Start by taking the tablet marked with that day. For example, if it is a Monday, take a tablet marked Monday on the upper row of the strip. Follow the days of the week until the strip is empty. Start the next strip the next day.
Do not leave a break between strips or packs.
HRT should be prescribed at the lowest effective dose and for the shortest duration necessary. Your doctor can advise you how long you may need to take Livial.
If you forget to take a tablet, take it as soon as you remember, unless you are more than 12 hours late. If you are more than 12 hours late, skip the dose you missed and take your next dose when you are meant to.
Do not take a double dose to make up for the forgotten dose.
If you have taken more tablets than you have been prescribed, immediately telephone your doctor or for Australia the Poisons Information Centre on 13 11 26, for New Zealand, the National Poisons Centre on 0800 764 766 for advice.
Signs of an overdose may include feeling sick or vomiting. Vaginal bleeding may also occur after a few days.
Tell your doctor and your surgeon that you are taking Livial if you are going to have surgery. You may need to stop taking Livial about 4-6 weeks before the operation to reduce the risk of a blood clot (see "Blood clots in a vein"). Ask your doctor when you can start taking Livial again.
Tell your doctor or pharmacist as soon as possible if you do not feel well while you are taking Livial.
The following diseases are reported more often in women using HRT compared to women not using HRT:
Livial helps most women with menopausal symptoms, but it may have unwanted side effects in a few people. All medicines can have side effects. Sometimes they are serious, most of the time they are not.
Do not be alarmed by the following lists of side effects. You may not experience any of them.
Common side effects observed in clinical studies (occurring in 1-10% of the women using Livial) were:
Uncommon side effects (occurring in 0.1-1% of the women using Livial) were:
Other side effects observed with Livial in market use were:
There have been reports of breast cancer and of an increased cell growth or cancer of the lining of the womb in women using Livial.
Tell your doctor if vaginal bleeding or spotting occurs or if any of the above mentioned side effects worry you or continue.
Please see "Medical history and regular check-ups" for conditions where Livial should be stopped.
The following side effects have been reported with other HRTs:
Tell your doctor or pharmacist if you notice any side effects not mentioned in this leaflet.
Keep your Livial tablets in a safe place out of the reach of children.
Keep your Livial tablets in the original package in a cool dry place where the temperature stays below 25°C.
Do not use after the expiry date stated on the blister and outer box.
If your doctor tells you to stop taking this medicine or the expiry date has passed, ask your pharmacist what to do with any medicine that is left over.
Packs contain one blister strip of 10 or 28 white round flat tablets with bevelled edges. The tablets are marked Organon and a star on one side and MK above 2 on the other.
Livial tablet contains 2.5 mg of the active ingredient called tibolone. Livial also contains the following inactive ingredients:
Do not use the product if the blister pack or tablets are damaged or appear unusual.
Merck Sharp & Dohme (Australia) Pty Limited
Level 1, Building A, 26 Talavera Rd,
Macquarie Park NSW 2113
Merck Sharp & Dohme (New Zealand) Limited
PO Box 99851
AUST R 55088
This leaflet was prepared July 2014.
Published by MIMS September 2014